Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 128 entries
Sorted by: Best Match Show Resources per page
Management of multiple sclerosis.

Postgraduate medicine

JONEZ HD.
PMID: 14920325
Postgrad Med. 1952 May;11(5):415-22. doi: 10.1080/00325481.1952.11694278.

No abstract available.

Cite
JONEZ HD. Management of multiple sclerosis. Postgrad Med. 1952;11(5):415-22doi: 10.1080/00325481.1952.11694278.
JONEZ, H. D. (1952). Management of multiple sclerosis. Postgraduate medicine, 11(5), 415-22. https://doi.org/10.1080/00325481.1952.11694278
JONEZ, H D. "Management of multiple sclerosis." Postgraduate medicine vol. 11,5 (1952): 415-22. doi: https://doi.org/10.1080/00325481.1952.11694278
JONEZ HD. Management of multiple sclerosis. Postgrad Med. 1952 May;11(5):415-22. doi: 10.1080/00325481.1952.11694278. PMID: 14920325.
Copy Download .nbib Format: NLM
Multiple sclerosis: new insights and trends.

AJNR. American journal of neuroradiology

Inglese M.
PMID: 16687523
AJNR Am J Neuroradiol. 2006 May;27(5):954-7.

No abstract available.

Cite
Inglese M. Multiple sclerosis: new insights and trends. AJNR Am J Neuroradiol. 2006;27(5):954-7
Inglese, M. (2006). Multiple sclerosis: new insights and trends. AJNR. American journal of neuroradiology, 27(5), 954-7.
Inglese, M. "Multiple sclerosis: new insights and trends." AJNR. American journal of neuroradiology vol. 27,5 (2006): 954-7.
Inglese M. Multiple sclerosis: new insights and trends. AJNR Am J Neuroradiol. 2006 May;27(5):954-7. PMID: 16687523; PMCID: PMC7975738.
Copy Download .nbib Format: NLM
Treatment decisions in multiple sclerosis - insights from real-world observational studies.

Nature reviews. Neurology

Trojano M, Tintore M, Montalban X, Hillert J, Kalincik T, Iaffaldano P, Spelman T, Sormani MP, Butzkueven H.
PMID: 28084327
Nat Rev Neurol. 2017 Feb;13(2):105-118. doi: 10.1038/nrneurol.2016.188. Epub 2017 Jan 13.

The complexity of multiple sclerosis (MS) treatment means that doctors and decision-makers need the best available evidence to make the best decisions for patient care. Randomized controlled trials (RCTs) are accepted as the gold standard for assessing the efficacy...

Cite
Trojano M, Tintore M, Montalban X, et al. Treatment decisions in multiple sclerosis - insights from real-world observational studies. Nat Rev Neurol. 2017;13(2):105-118doi: 10.1038/nrneurol.2016.188.
Trojano, M., Tintore, M., Montalban, X., Hillert, J., Kalincik, T., Iaffaldano, P., Spelman, T., Sormani, M. P., & Butzkueven, H. (2017). Treatment decisions in multiple sclerosis - insights from real-world observational studies. Nature reviews. Neurology, 13(2), 105-118. https://doi.org/10.1038/nrneurol.2016.188
Trojano, Maria, et al. "Treatment decisions in multiple sclerosis - insights from real-world observational studies." Nature reviews. Neurology vol. 13,2 (2017): 105-118. doi: https://doi.org/10.1038/nrneurol.2016.188
Trojano M, Tintore M, Montalban X, Hillert J, Kalincik T, Iaffaldano P, Spelman T, Sormani MP, Butzkueven H. Treatment decisions in multiple sclerosis - insights from real-world observational studies. Nat Rev Neurol. 2017 Feb;13(2):105-118. doi: 10.1038/nrneurol.2016.188. Epub 2017 Jan 13. PMID: 28084327.
Copy Download .nbib Format: NLM
Epidemiology of Multiple Sclerosis.

Neurologic clinics

Howard J, Trevick S, Younger DS.
PMID: 27720001
Neurol Clin. 2016 Nov;34(4):919-939. doi: 10.1016/j.ncl.2016.06.016. Epub 2016 Aug 18.

The epidemiology of multiple sclerosis (MS) includes a consideration of genetic and environmental factors. Comparative studies of different populations have revealed prevalence and incidence rates that vary with geography and ethnicity. With a prevalence ranging from 2 per 100,000...

Cite
Howard J, Trevick S, Younger DS. Epidemiology of Multiple Sclerosis. Neurol Clin. 2016;34(4):919-939doi: 10.1016/j.ncl.2016.06.016.
Howard, J., Trevick, S., & Younger, D. S. (2016). Epidemiology of Multiple Sclerosis. Neurologic clinics, 34(4), 919-939. https://doi.org/10.1016/j.ncl.2016.06.016
Howard, Jonathan, et al. "Epidemiology of Multiple Sclerosis." Neurologic clinics vol. 34,4 (2016): 919-939. doi: https://doi.org/10.1016/j.ncl.2016.06.016
Howard J, Trevick S, Younger DS. Epidemiology of Multiple Sclerosis. Neurol Clin. 2016 Nov;34(4):919-939. doi: 10.1016/j.ncl.2016.06.016. Epub 2016 Aug 18. PMID: 27720001.
Copy Download .nbib Format: NLM
The effectiveness of interventions targeting physical activity and/or sedentary behaviour in people with Multiple Sclerosis: a systematic review.

Disability and rehabilitation

Coulter EH, Bond S, Dalgas U, Paul L.
PMID: 30290702
Disabil Rehabil. 2020 Mar;42(5):594-612. doi: 10.1080/09638288.2018.1503737. Epub 2018 Oct 05.

No abstract available.

Cite
Coulter EH, Bond S, Dalgas U, et al. The effectiveness of interventions targeting physical activity and/or sedentary behaviour in people with Multiple Sclerosis: a systematic review. Disabil Rehabil. 2018;42(5):594-612doi: 10.1080/09638288.2018.1503737.
Coulter, E. H., Bond, S., Dalgas, U., & Paul, L. (2020). The effectiveness of interventions targeting physical activity and/or sedentary behaviour in people with Multiple Sclerosis: a systematic review. Disability and rehabilitation, 42(5), 594-612. https://doi.org/10.1080/09638288.2018.1503737
Coulter, Elaine H, et al. "The effectiveness of interventions targeting physical activity and/or sedentary behaviour in people with Multiple Sclerosis: a systematic review." Disability and rehabilitation vol. 42,5 (2020): 594-612. doi: https://doi.org/10.1080/09638288.2018.1503737
Coulter EH, Bond S, Dalgas U, Paul L. The effectiveness of interventions targeting physical activity and/or sedentary behaviour in people with Multiple Sclerosis: a systematic review. Disabil Rehabil. 2020 Mar;42(5):594-612. doi: 10.1080/09638288.2018.1503737. Epub 2018 Oct 05. PMID: 30290702.
Copy Download .nbib Format: NLM
MS: is it one disease?.

International MS journal

Barnett MH, Parratt JD, Pollard JD, Prineas JW.
PMID: 19671369
Int MS J. 2009 Jun;16(2):57-65.

Neuropathological studies of early multiple sclerosis (MS) tissue have shaped prevailing views of the pathogenesis of the disease. The hallmark of the acute MS lesion, inflammatory demyelination, has been largely accepted as evidence of a macrophage-mediated attack on normal...

Cite
Barnett MH, Parratt JD, Pollard JD, et al. MS: is it one disease?. Int MS J. 2009;16(2):57-65
Barnett, M. H., Parratt, J. D., Pollard, J. D., & Prineas, J. W. (2009). MS: is it one disease?. International MS journal, 16(2), 57-65.
Barnett, M H, et al. "MS: is it one disease?." International MS journal vol. 16,2 (2009): 57-65.
Barnett MH, Parratt JD, Pollard JD, Prineas JW. MS: is it one disease?. Int MS J. 2009 Jun;16(2):57-65. PMID: 19671369.
Copy Download .nbib Format: NLM
[Recent advances of multiple sclerosis research in Japan].

Rinsho shinkeigaku = Clinical neurology

Kira J.
PMID: 19928684
Rinsho Shinkeigaku. 2009 Sep;49(9):549-59. doi: 10.5692/clinicalneurol.49.549.

Multiple sclerosis (MS) is rare in Asians, but selective and severe involvement of the optic nerve and spinal cord is characteristic when it does occur. Recent epidemiological studies have demonstrated an increase in the prevalence of MS in Japan....

Cite
Kira J. [Recent advances of multiple sclerosis research in Japan]. Rinsho Shinkeigaku. 2009;49(9):549-59doi: 10.5692/clinicalneurol.49.549.
Kira, J. (2009). [Recent advances of multiple sclerosis research in Japan]. Rinsho shinkeigaku = Clinical neurology, 49(9), 549-59. https://doi.org/10.5692/clinicalneurol.49.549
Kira, Jun-ichi. "[Recent advances of multiple sclerosis research in Japan]." Rinsho shinkeigaku = Clinical neurology vol. 49,9 (2009): 549-59. doi: https://doi.org/10.5692/clinicalneurol.49.549
Kira J. [Recent advances of multiple sclerosis research in Japan]. Rinsho Shinkeigaku. 2009 Sep;49(9):549-59. doi: 10.5692/clinicalneurol.49.549. Japanese. PMID: 19928684.
Copy Download .nbib Format: NLM
What is new in symptom management?.

International MS journal

Henze T.
PMID: 17509249
Int MS J. 2007 Mar;14(1):22-7.

Many people with MS suffer from severe and disabling symptoms that restrict their social and private lives, and hence affect their quality of life; it is, therefore, essential that any symptoms that they experience are reduced effectively. Symptomatic treatment...

Cite
Henze T. What is new in symptom management?. Int MS J. 2007;14(1):22-7
Henze, T. (2007). What is new in symptom management?. International MS journal, 14(1), 22-7.
Henze, T. "What is new in symptom management?." International MS journal vol. 14,1 (2007): 22-7.
Henze T. What is new in symptom management?. Int MS J. 2007 Mar;14(1):22-7. PMID: 17509249.
Copy Download .nbib Format: NLM
NICE recommendations have had little effect on multiple sclerosis services five years on.

BMJ (Clinical research ed.)

Hitchen L.
PMID: 18614502
BMJ. 2008 Jul 08;337:a734. doi: 10.1136/bmj.a734.

No abstract available.

Cite
Hitchen L. NICE recommendations have had little effect on multiple sclerosis services five years on. BMJ. 2008;337:a734doi: 10.1136/bmj.a734.
Hitchen, L. (2008). NICE recommendations have had little effect on multiple sclerosis services five years on. BMJ (Clinical research ed.), 337a734. https://doi.org/10.1136/bmj.a734
Hitchen, Lisa. "NICE recommendations have had little effect on multiple sclerosis services five years on." BMJ (Clinical research ed.) vol. 337 (2008): a734. doi: https://doi.org/10.1136/bmj.a734
Hitchen L. NICE recommendations have had little effect on multiple sclerosis services five years on. BMJ. 2008 Jul 08;337:a734. doi: 10.1136/bmj.a734. PMID: 18614502; PMCID: PMC2453262.
Copy Download .nbib Format: NLM
Exercise, drug treatment, and the optimal care of multiple sclerosis patients.

Annals of neurology

Johnson KB.
PMID: 8619519
Ann Neurol. 1996 Apr;39(4):422-3. doi: 10.1002/ana.410390403.

No abstract available.

Cite
Johnson KB. Exercise, drug treatment, and the optimal care of multiple sclerosis patients. Ann Neurol. 1996;39(4):422-3doi: 10.1002/ana.410390403.
Johnson, K. B. (1996). Exercise, drug treatment, and the optimal care of multiple sclerosis patients. Annals of neurology, 39(4), 422-3. https://doi.org/10.1002/ana.410390403
Johnson, K B. "Exercise, drug treatment, and the optimal care of multiple sclerosis patients." Annals of neurology vol. 39,4 (1996): 422-3. doi: https://doi.org/10.1002/ana.410390403
Johnson KB. Exercise, drug treatment, and the optimal care of multiple sclerosis patients. Ann Neurol. 1996 Apr;39(4):422-3. doi: 10.1002/ana.410390403. PMID: 8619519.
Copy Download .nbib Format: NLM
Models of Care in Multiple Sclerosis. Atlanta, Georgia, USA, September 27-29, 1996. Abstracts.

Multiple sclerosis (Houndmills, Basingstoke, England)

[No authors listed]
PMID: 9410580
Mult Scler. 1996 Sep;2(2):96-119. doi: 10.1177/135245859600200207.

No abstract available.

Cite
Models of Care in Multiple Sclerosis. Atlanta, Georgia, USA, September 27-29, 1996. Abstracts. Mult Scler. 1996;2(2):96-119doi: 10.1177/135245859600200207.
(1996). Models of Care in Multiple Sclerosis. Atlanta, Georgia, USA, September 27-29, 1996. Abstracts. Multiple sclerosis (Houndmills, Basingstoke, England), 2(2), 96-119. https://doi.org/10.1177/135245859600200207
"Models of Care in Multiple Sclerosis. Atlanta, Georgia, USA, September 27-29, 1996. Abstracts." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 2,2 (1996): 96-119. doi: https://doi.org/10.1177/135245859600200207
Models of Care in Multiple Sclerosis. Atlanta, Georgia, USA, September 27-29, 1996. Abstracts. Mult Scler. 1996 Sep;2(2):96-119. doi: 10.1177/135245859600200207. PMID: 9410580.
Copy Download .nbib Format: NLM
Patient selection and criteria.

Archives of neurology

Paty DW, Davis FA.
PMID: 6625979
Arch Neurol. 1983 Oct 21;40(11):701. doi: 10.1001/archneur.1983.04050100041015.

No abstract available.

Cite
Paty DW, Davis FA. Patient selection and criteria. Arch Neurol. 1983;40(11):701doi: 10.1001/archneur.1983.04050100041015.
Paty, D. W., & Davis, F. A. (1983). Patient selection and criteria. Archives of neurology, 40(11), 701. https://doi.org/10.1001/archneur.1983.04050100041015
Paty, D W, and Davis, F A. "Patient selection and criteria." Archives of neurology vol. 40,11 (1983): 701. doi: https://doi.org/10.1001/archneur.1983.04050100041015
Paty DW, Davis FA. Patient selection and criteria. Arch Neurol. 1983 Oct 21;40(11):701. doi: 10.1001/archneur.1983.04050100041015. PMID: 6625979.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 128 entries